一例用托珠单抗治疗的泛硬化性硬斑病病例。 - Suppr

Suppr

超能文献

A Case of Pansclerotic Morphea Treated With Tocilizumab.

作者信息

Zhang April, Nocton James, Chiu Yvonne

机构信息

Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin.

Department of Pediatrics (Rheumatology), Medical College of Wisconsin, Milwaukee, Wisconsin.

出版信息

JAMA Dermatol. 2019 Mar 1;155(3):388-389. doi: 10.1001/jamadermatol.2018.5040.

DOI:10.1001/jamadermatol.2018.5040

PMID:30649148

Abstract

摘要

相似文献

A Case of Pansclerotic Morphea Treated With Tocilizumab.

JAMA Dermatol. 2019 Mar 1;155(3):388-389. doi: 10.1001/jamadermatol.2018.5040.

Low effectiveness of methotrexate in the management of localised scleroderma (morphea) based on an ultrasound activity score.

Eur J Dermatol. 2021 Dec 1;31(6):813-821. doi: 10.1684/ejd.2021.4189.

Update on the classification and treatment of localized scleroderma.

Actas Dermosifiliogr. 2013 Oct;104(8):654-66. doi: 10.1016/j.adengl.2012.10.012. Epub 2013 Aug 13.

Case Report: Pansclerotic Morphea-Clinical Features, Differential Diagnoses and Modern Treatment Concepts.

Front Immunol. 2021 Mar 9;12:656407. doi: 10.3389/fimmu.2021.656407. eCollection 2021.

Disabling pansclerotic morphea of childhood--unusual case and management challenges.

J Med Life. 2008 Jul-Sep;1(3):348-54.

Scleroderma "en coup de sabre" With Epilepsy and Uveitis Successfully Treated With Tocilizumab.

Reumatol Clin (Engl Ed). 2020 Sep-Oct;16(5 Pt 1):356-358. doi: 10.1016/j.reuma.2018.05.001. Epub 2018 Jul 9.

Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma.

Rheumatology (Oxford). 2021 Mar 2;60(3):1387-1391. doi: 10.1093/rheumatology/keaa392.

Tocilizumab for refractory post-COVID-19 pansclerotic morphea.

J Eur Acad Dermatol Venereol. 2024 May;38(5):e364-e365. doi: 10.1111/jdv.19692. Epub 2023 Dec 11.

New developments in juvenile systemic and localized scleroderma.

Rheum Dis Clin North Am. 2013 Nov;39(4):905-20. doi: 10.1016/j.rdc.2013.05.003. Epub 2013 Jul 16.

Tocilizumab in two children with pansclerotic morphoea: a hopeful therapy for refractory cases?

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):211-213. Epub 2017 Sep 29.

引用本文的文献

New Challenging Systemic Therapies for Juvenile Scleroderma: A Comprehensive Review.

Pharmaceuticals (Basel). 2025 Apr 28;18(5):643. doi: 10.3390/ph18050643.

What Is New in Morphea-Narrative Review on Molecular Aspects and New Targeted Therapies.

J Clin Med. 2024 Nov 25;13(23):7134. doi: 10.3390/jcm13237134.

Targeted therapy for immune mediated skin diseases. What should a dermatologist know?

An Bras Dermatol. 2024 Jul-Aug;99(4):546-567. doi: 10.1016/j.abd.2023.10.002. Epub 2024 Mar 22.

[Juvenile localized scleroderma].

Dermatologie (Heidelb). 2024 Mar;75(3):208-213. doi: 10.1007/s00105-023-05293-5. Epub 2024 Jan 19.

Recent Advances in Treatment of Systemic Sclerosis and Morphea.

Am J Clin Dermatol. 2024 Mar;25(2):213-226. doi: 10.1007/s40257-023-00831-2. Epub 2023 Dec 12.

Morphea: The 2023 update.

Front Med (Lausanne). 2023 Feb 13;10:1108623. doi: 10.3389/fmed.2023.1108623. eCollection 2023.

Tocilizumab for refractory morphea in adults: A case series.

JAAD Case Rep. 2022 Oct 4;30:27-29. doi: 10.1016/j.jdcr.2022.09.024. eCollection 2022 Dec.

Case Report: Pansclerotic Morphea-Clinical Features, Differential Diagnoses and Modern Treatment Concepts.

Front Immunol. 2021 Mar 9;12:656407. doi: 10.3389/fimmu.2021.656407. eCollection 2021.

Update on Management of Morphea (Localized Scleroderma) in Children.

Indian Dermatol Online J. 2020 Mar 9;11(2):135-145. doi: 10.4103/idoj.IDOJ_284_19. eCollection 2020 Mar-Apr.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

A Case of Pansclerotic Morphea Treated With Tocilizumab.

JAMA Dermatol. 2019 Mar 1;155(3):388-389. doi: 10.1001/jamadermatol.2018.5040.

Low effectiveness of methotrexate in the management of localised scleroderma (morphea) based on an ultrasound activity score.

Eur J Dermatol. 2021 Dec 1;31(6):813-821. doi: 10.1684/ejd.2021.4189.

Update on the classification and treatment of localized scleroderma.

Actas Dermosifiliogr. 2013 Oct;104(8):654-66. doi: 10.1016/j.adengl.2012.10.012. Epub 2013 Aug 13.

Case Report: Pansclerotic Morphea-Clinical Features, Differential Diagnoses and Modern Treatment Concepts.

Front Immunol. 2021 Mar 9;12:656407. doi: 10.3389/fimmu.2021.656407. eCollection 2021.

Disabling pansclerotic morphea of childhood--unusual case and management challenges.

J Med Life. 2008 Jul-Sep;1(3):348-54.

Scleroderma "en coup de sabre" With Epilepsy and Uveitis Successfully Treated With Tocilizumab.

Reumatol Clin (Engl Ed). 2020 Sep-Oct;16(5 Pt 1):356-358. doi: 10.1016/j.reuma.2018.05.001. Epub 2018 Jul 9.

Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma.

Rheumatology (Oxford). 2021 Mar 2;60(3):1387-1391. doi: 10.1093/rheumatology/keaa392.

Tocilizumab for refractory post-COVID-19 pansclerotic morphea.

J Eur Acad Dermatol Venereol. 2024 May;38(5):e364-e365. doi: 10.1111/jdv.19692. Epub 2023 Dec 11.

New developments in juvenile systemic and localized scleroderma.

Rheum Dis Clin North Am. 2013 Nov;39(4):905-20. doi: 10.1016/j.rdc.2013.05.003. Epub 2013 Jul 16.

Tocilizumab in two children with pansclerotic morphoea: a hopeful therapy for refractory cases?

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):211-213. Epub 2017 Sep 29.

引用本文的文献

New Challenging Systemic Therapies for Juvenile Scleroderma: A Comprehensive Review.

Pharmaceuticals (Basel). 2025 Apr 28;18(5):643. doi: 10.3390/ph18050643.

What Is New in Morphea-Narrative Review on Molecular Aspects and New Targeted Therapies.

J Clin Med. 2024 Nov 25;13(23):7134. doi: 10.3390/jcm13237134.

Targeted therapy for immune mediated skin diseases. What should a dermatologist know?

An Bras Dermatol. 2024 Jul-Aug;99(4):546-567. doi: 10.1016/j.abd.2023.10.002. Epub 2024 Mar 22.

[Juvenile localized scleroderma].

Dermatologie (Heidelb). 2024 Mar;75(3):208-213. doi: 10.1007/s00105-023-05293-5. Epub 2024 Jan 19.

Recent Advances in Treatment of Systemic Sclerosis and Morphea.

Am J Clin Dermatol. 2024 Mar;25(2):213-226. doi: 10.1007/s40257-023-00831-2. Epub 2023 Dec 12.

Morphea: The 2023 update.

Front Med (Lausanne). 2023 Feb 13;10:1108623. doi: 10.3389/fmed.2023.1108623. eCollection 2023.

Tocilizumab for refractory morphea in adults: A case series.

JAAD Case Rep. 2022 Oct 4;30:27-29. doi: 10.1016/j.jdcr.2022.09.024. eCollection 2022 Dec.

Case Report: Pansclerotic Morphea-Clinical Features, Differential Diagnoses and Modern Treatment Concepts.

Front Immunol. 2021 Mar 9;12:656407. doi: 10.3389/fimmu.2021.656407. eCollection 2021.

Update on Management of Morphea (Localized Scleroderma) in Children.

Indian Dermatol Online J. 2020 Mar 9;11(2):135-145. doi: 10.4103/idoj.IDOJ_284_19. eCollection 2020 Mar-Apr.